Verastem (VSTM) Liabilities and Shareholders Equity (2011 - 2026)

Verastem's Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $227.8 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 72.98% year-over-year to $227.8 million; the TTM figure through Mar 2026 stood at $847.4 million (up 82.09% YoY), while the FY2025 annual figure was $246.4 million, up 142.71% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $227.8 million, down from $246.4 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $246.4 million in Q4 2025, with the low at $95.0 million in Q4 2022.
• The 5-year median for Liabilities and Shareholders Equity is $126.4 million (2024), against an average of $146.9 million.
• The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity plunged 44.85% in 2024, then surged 142.71% in 2025.
• Verastem's Liabilities and Shareholders Equity stood at $95.0 million in 2022, then surged by 57.51% to $149.7 million in 2023, then sank by 32.18% to $101.5 million in 2024, then soared by 142.71% to $246.4 million in 2025, then declined by 7.56% to $227.8 million in 2026.
• Business Quant data shows VSTM's Liabilities and Shareholders Equity at $227.8 million in Q1 2026, $246.4 million in Q4 2025, and $176.9 million in Q3 2025.